Importantly, the fusion protein could profoundly inhibit differentiation and colony formation of primary CD34+ hematopoietic stem/progenitor cells in vitro (Fig. 2h), strongly implicating RUNX1::ERG as an AML driver mutation. The gene discussed is RUNX1; the disease is acute myeloid leukemia.